Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis
Stopped early · Phase 4
Conditions studied: Atopic Dermatitis
In brief
This single blind study is to primarily evaluate wearable devices and Observer Reported Itch Assessment in children to assess reduction of itch and night-time scratch in response to Crisaborole treatment vs. vehicle treatment (active control comparator without crisaborole) in children with atopic dermatitis (AD). Participants, age 3 months to 11 years with symptomatic mild to moderate AD, along with their primary caregivers will be recruited. The goal of this study is to more fully evaluate the rapid onset of night-time itch and scratch relief, as well as improvements in sleep following treatment with Crisaborole in comparison to vehicle treatment in children with AD. the study will also assess the quality of life (QoL) and sleep within the associated caregivers.
Key facts
- Study ID
- NCT05200403
- Run by
- Boston University
- People needed
- 72
- Starts
- 2022-07-26
- Expected to finish
- 2024-02-15
- Last updated by the study team
- 2025-03-14
Who can join
Age: 0 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- BU CAMed Laboratory for Human Neurobiology — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.